Algert Global’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $742K | Buy |
55,570
+28,090
| +102% | +$375K | 0.02% | 863 |
|
|
2025
Q1 | $280K | Buy |
27,480
+14,783
| +116% | +$151K | 0.01% | 1025 |
|
|
2024
Q4 | $201K | Buy |
12,697
+2,617
| +26% | +$41.4K | ﹤0.01% | 1076 |
|
|
2024
Q3 | $585K | Sell |
10,080
-5,620
| -36% | -$326K | 0.02% | 870 |
|
|
2024
Q2 | $717K | Buy |
15,700
+1,505
| +11% | +$68.7K | 0.02% | 776 |
|
|
2024
Q1 | $940K | Buy |
14,195
+3,560
| +33% | +$236K | 0.04% | 627 |
|
|
2023
Q4 | $423K | Hold |
10,635
| – | – | 0.02% | 865 |
|
|
2023
Q3 | $339K | Sell |
10,635
-5,960
| -36% | -$190K | 0.02% | 857 |
|
|
2023
Q2 | $667K | Hold |
16,595
| – | – | 0.03% | 752 |
|
|
2023
Q1 | $709K | Buy |
+16,595
| New | +$709K | 0.03% | 744 |
|